NCT02595762Completed
A Study of Treatment Patterns and Outcomes in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer
A Disease Registry Study to Prospectively Observe Treatment Patterns and Outcomes in Patients With HER2-Positive Unresectable Locally Advanced or Metastatic Breast Cancer
Source: ClinicalTrials.gov · Last updated 19 Aug 2024
Brief summary (registry, in English)
This disease registry is a prospective, multicenter non-interventional study designed to observe anti-cancer treatment regimens and clinical outcomes in participants with HER2-positive unresectable locally advanced breast cancer (LABC) or metastatic breast cancer (MBC).
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 110 (actual)
- First submitted
- 28 Oct 2015
- Start date
- 30 Oct 2016
- Primary completion date
- 30 Nov 2023
- Lead sponsor
- Hoffmann-La Roche
- Diseases
- Metastatic breast cancer
- NCT number
- NCT02595762
What you commit to
- Study type: Observational
- Participants enrolled: 110
- From 30 Oct 2016 to the primary completion date, 30 Nov 2023
- 12 sites in 2 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- None specified
Who the study is looking for
- Diagnosis of HER2-positive unresectable LABC or MBC within 6 months prior to enrollment
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (12)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Bank of Cyprus Oncology Center Coordinator of this site? Confirm its status | Nicosia | Cyprus | Unknown status |
| Anticancer Hospital Ag. Savas ; 2Nd Dept. of Oncology - Internal Medicine Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| Anticancer Hospital Ag Savas; 1St Dept of Internal Medicine Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| ARETAIEION UNIVERSITY HOSPITAL; oncology unit Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| IASO General Hospital of Athens Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| 251 Air Force General Hospital-Oncology Clinic Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| Agioi Anargyroi; 3Rd Dept. of Medical Oncology Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| IASO Coordinator of this site? Confirm its status | Athens | Greece | Unknown status |
| Attikon University Hospital; 4th Department of Internal Medicine Coordinator of this site? Confirm its status | Haidari | Greece | Unknown status |
| Metropolitan Hospital; 2Nd Oncology Clinic Coordinator of this site? Confirm its status | Piraeus | Greece | Unknown status |
| Papageorgiou General Hospital; Medical Oncology Coordinator of this site? Confirm its status | Thessaloniki | Greece | Unknown status |
| Theagenio Anticancer Hospital; 3Rd Oncology Clinic Coordinator of this site? Confirm its status | Thessaloniki | Greece | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.